HOME >> MEDICINE >> NEWS
Experimental pill found to improve symptoms in patients with non-small-cell lung cancer

ORLANDO, FLA. (May 19, 2002, 12:00 p.m., EST) An experimental pill has been found to improve symptoms and quality of life in patients with non-small-cell lung cancer, according to research findings presented by Ronald B. Natale, M.D., Acting Medical Director at Cedars-Sinai Comprehensive Cancer Center, and lead author of the study. The pill, called ZD 1839 (Iressa) is one of a new class of drugs that targets and blocks a key growth signal in cancer cells.

The study, presented at the 38th annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, evaluated 216 patients with recurrent non-small-cell lung cancer who had undergone two or more rounds of chemotherapy. One group of patients received 250 mg of ZD 1839 (Iressa) daily, while the second group received ZD 1839 at 500 mg each day until the disease progressed. The investigators found that lung cancer symptoms, such as cough, shortness of breath, chest pain or tightness, appetite and fatigue, were greatly improved in about 40 percent of patients. Further, they found that symptom improvement was associated with a longer survival.

Our results show that patients who felt better after taking ZD 1839, actually lived longer than those whose symptoms did not improve, said Dr. Natale. This is important because it shows that a daily pill reduced symptoms such to the extent that many of our patients were able to resume their normal activities and enjoy life for longer.

ZD 1839 (Iressa), a pill developed by AstraZeneca, has been found to work in both laboratory and clinical trials by targeting and blocking a key growth signaling mechanism in cancer cells called the epidermal growth factor receptor (EGFR). Otherwise known as HER1, the EGFR is a part of the HER kinase family of proteins that control cell growth and can stimulate the spread of cancer when over-expressed on malignant cells.

Non-small-cell lung cancer is the most common type of lung cancer,
'"/>

Contact: Kelli Stauning
kelli.stauning@cshs.org
310-423-3674
Cedars-Sinai Medical Center
19-May-2002


Page: 1 2 3

Related medicine news :

1. St. Jude scientist wins International Society of Experimental Hematology award
2. Experimental drug improves sleep in older patients, Wake Forest Baptist study shows
3. Experimental drug used to treat recurrent ovarian cancer shows promising results
4. Experimental treatment yields new hope for children battling cerebral palsy
5. Experimental drugs show promise in halting brain tumors
6. Experimental drugs reduce neuron death in rats following insulin shock
7. Experimental drug reverses effects of Fabry disease in mice
8. Experimental peptides prevent diabetes and halt its progression
9. Experimental testosterone patch shows promise for treating diminished sexual function in surgically menopausal women
10. Clinical Trial Demonstrates Experimental Growth Factor Increases Eligibility For Autologous Stem Cell Transplantation
11. Acupuncture found to lower elevations in blood pressure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/30/2020)... ... 29, 2020 , ... Worldwide Business with kathy ireland® will be LIVE streaming ... Wednesday, June 3, 2020 at 8:00pm ET / PT – two chances to watch each ... Med , and Diagnostic Solutions Laboratory . , As leaders in ...
(Date:5/30/2020)... ... May 29, 2020 , ... In appreciation for all the ... ever, James Hodge Hyundai is offering a $500 bonus towards the lease or purchase ... incentive now through January 4, 2021. , To qualify for this offer, individuals must ...
(Date:5/28/2020)... (PRWEB) , ... May 28, 2020 , ... ... healthcare organization is joining the clinically integrated network (CIN) and the group purchasing ... with AHN’s Cardiovascular Institute to establish a heart failure program at Mon Health ...
(Date:5/28/2020)... , ... May 28, 2020 , ... ... fully re-open in the fall, operators of student housing are scrambling to implement ... COCM, which manages over 37,000 student housing beds on 38 campuses across the ...
(Date:5/27/2020)... ... 27, 2020 , ... The podiatrists and foot doctors of Advanced Foot & ... , and Ann Arbor Michigan. Dr. Tomasz Biernacki states that “Podiatrists can ... at the hospital. We have been seeing patients in the hospital for the past ...
Breaking Medicine News(10 mins):
(Date:5/28/2020)... ... May 28, 2020 , ... This new Notify.com ... is an acknowledgement-based notification platform,” said Bob Lueth, President of Notify.com. “This ... SMS text message, Email or Voice phone call—will be tracked by Notify.com, in ...
(Date:5/27/2020)... ... May 27, 2020 , ... NDA Partners Chairman Carl ... with more than 25 years of experience in product design, development, and manufacturing ... Consultant. His expertise includes quality assurance, including ISO 13485 and FDA QSR (21 ...
(Date:5/27/2020)... ... May 27, 2020 , ... Hemp Health One’s Giving Away Free CBD Supplements for the next ... 60 days. The company is hosting the daily giveaway contest on its Instagram and Facebook ... One’s Instagram page or Hemp Health One’s Facebook page. Then, like the most recent post, ...
Breaking Medicine Technology:
Cached News: